Cross-reactive broadly neutralizing antibodies: timing is everything

por Euler, Zelda, Schuitemaker, Hanneke
Publicado 2012

Inactivated Viral Vaccines

por Sanders, Barbara, Koldijk, Martin, Schuitemaker, Hanneke
Publicado 2014

Clinical significance of HIV-1 coreceptor usage

por Schuitemaker, Hanneke, van 't Wout, Angélique B, Lusso, Paolo
Publicado 2011

Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics

por van Manen, Daniëlle, van ‘t Wout, Angélique B, Schuitemaker, Hanneke
Publicado 2012

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients

por van den Kerkhof, Tom, van Gils, Marit, Euler, Zelda, Verwer, Naomi, Sanders, Rogier, Schuitemaker, Hanneke
Publicado 2011

Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals

por Euler, Zelda, van Gils, Marit J., Boeser-Nunnink, Brigitte D., Schuitemaker, Hanneke, van Manen, Daniëlle
Publicado 2013

The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection

por van Manen, Daniëlle, Rits, Maarten A. N, Beugeling, Corrine, van Dort, Karel, Schuitemaker, Hanneke, Kootstra, Neeltje A
Publicado 2008

Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs

por Navis, Marjon, Edo Matas, Diana, Rachinger, Andrea, Koning, Fransje A., van Swieten, Peter, Kootstra, Neeltje A., Schuitemaker, Hanneke
Publicado 2008

HIV-1 Replication Fitness of HLA-B*57/58:01 CTL Escape Variants Is Restored by the Accumulation of Compensatory Mutations in Gag

por Gijsbers, Esther F., Feenstra, K. Anton, van Nuenen, Ad C., Navis, Marjon, Heringa, Jaap, Schuitemaker, Hanneke, Kootstra, Neeltje A.
Publicado 2013

2775. Safety and Immunogenicity of a Seasonal Influenza Vaccine and Ad26.RSV.preF Vaccine With and Without Co-Administration: A Randomized, Double-Blind, Placebo-Controlled Phase 2...

por Comeaux, Christy, Bastian, Arangassery Rosemary, Paepe, Els De, Omoruyi, Edmund, Haazen, Wouter, Schuitemaker, Hanneke, Strout, Cynthia, Callendret, Benoit, Sadoff, Jerald
Publicado 2019

Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets

por Khan, Selina, Salisch, Nadine C., Gil, Ana Izquierdo, Boedhoe, Satish, Boer, Karin Feddes-de, Serroyen, Jan, Schuitemaker, Hanneke, Zahn, Roland C.
Publicado 2022

Polymorphism in HIV-1 dependency factor PDE8A affects gene expression and HIV-1 replication in primary macrophages

por Booiman, Thijs, Bol, Sebastiaan, Bunnik, Evelien, Moerland, Perry, van Dort, Karel, Strauss, Jerome, Síeberer, Margit, Schuitemaker, Hanneke, Kootstra, Neeltje, van't Wout, Angélique
Publicado 2011

Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data

por Poon, Art F. Y., Swenson, Luke C., Bunnik, Evelien M., Edo-Matas, Diana, Schuitemaker, Hanneke, van 't Wout, Angélique B., Harrigan, P. Richard
Publicado 2012

HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans

por Malherbe, Delphine C., Sanders, Rogier W., van Gils, Marit J., Park, Byung, Gomes, Michelle M., Schuitemaker, Hanneke, Barnett, Susan, Haigwood, Nancy L.
Publicado 2013

An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model

por Bockstal, Viki, Tiemessen, Machteld M., Achterberg, Rogier, Van Wordragen, Carlo, Knaapen, Ad M., Serroyen, Jan, Marissen, Wilfred E., Schuitemaker, Hanneke, Zahn, Roland
Publicado 2018

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection

por Jacob-Dolan, Catherine, Feldman, Jared, McMahan, Katherine, Yu, Jingyou, Zahn, Roland, Wegmann, Frank, Schuitemaker, Hanneke, Schmidt, Aaron G., Barouch, Dan H.
Publicado 2021

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

por Leroux-Roels, Isabel, Leroux-Roels, Geert, Shukarev, Georgi, Schuitemaker, Hanneke, Cahill, Conor, de Rooij, Richard, Struijs, Martin, van Zeeburg, Hester, Jacquet, Jeanne-Marie
Publicado 2020

The Role of Innate APOBEC3G and Adaptive AID Immune Responses in HLA-HIV/SIV Immunized SHIV Infected Macaques

por Wang, Yufei, Whittall, Trevor, Rahman, Durdana, Bunnik, Evelien M., Vaughan, Robert, Schøller, Jørgen, Bergmeier, Lesley A., Montefiori, David, Singh, Mahavir, Schuitemaker, Hanneke, Lehner, Thomas
Publicado 2012

Low level of HIV-1 evolution after transmission from mother to child

por Gijsbers, Esther F., van Nuenen, Ad C., de la Peňa, Alba Torrents, Bowles, Emma J., Stewart-Jones, Guillaume B., Schuitemaker, Hanneke, Kootstra, Neeltje A.
Publicado 2014

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine( )

por Le Gars, Mathieu, Sadoff, Jerald, Struyf, Frank, Heerwegh, Dirk, Truyers, Carla, Hendriks, Jenny, Gray, Glenda, Grinsztejn, Beatriz, Goepfert, Paul A, Schuitemaker, Hanneke, Douoguih, Macaya
Publicado 2022